Scholars@Duke
Journal cover image

HIV-1 sensitivity to zidovudine and clinical outcome.

Publication ,  Journal Article
Maxeiner, HG; Habermehl, KO; Grünewald, T; Ruf, B
Published in: Lancet
March 7, 1992
Link to item

Duke Scholars

Ross Erwin McKinney Jr.
Author Ross Erwin McKinney Jr. Pediatrics, Infectious Diseases
Emmanuel Benjamin Walter Jr.
Author Emmanuel Benjamin Walter Jr. Pediatrics, General Pediatrics and Adolescent Health

Published In

Lancet

ISSN

0140-6736

Publication Date

March 7, 1992

Volume

339

Issue

8793

Start / End Page

626 / 627

Location

England

Related Subject Headings

  • Zidovudine
  • T-Lymphocytes
  • Humans
  • HIV Seropositivity
  • HIV Infections
  • General & Internal Medicine
  • Drug Resistance, Microbial
  • Child
  • Cells, Cultured
  • Adult
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Maxeiner, H. G., Habermehl, K. O., Grünewald, T., & Ruf, B. (1992). HIV-1 sensitivity to zidovudine and clinical outcome. Lancet, 339(8793), 626–627.
Maxeiner, H. G., K. O. Habermehl, T. Grünewald, and B. Ruf. “HIV-1 sensitivity to zidovudine and clinical outcome.” Lancet 339, no. 8793 (March 7, 1992): 626–27.
Maxeiner HG, Habermehl KO, Grünewald T, Ruf B. HIV-1 sensitivity to zidovudine and clinical outcome. Lancet. 1992 Mar 7;339(8793):626–7.
Maxeiner, H. G., et al. “HIV-1 sensitivity to zidovudine and clinical outcome.” Lancet, vol. 339, no. 8793, Mar. 1992, pp. 626–27.
Maxeiner HG, Habermehl KO, Grünewald T, Ruf B. HIV-1 sensitivity to zidovudine and clinical outcome. Lancet. 1992 Mar 7;339(8793):626–627.
Journal cover image

Published In

Lancet

ISSN

0140-6736

Publication Date

March 7, 1992

Volume

339

Issue

8793

Start / End Page

626 / 627

Location

England

Related Subject Headings

  • Zidovudine
  • T-Lymphocytes
  • Humans
  • HIV Seropositivity
  • HIV Infections
  • General & Internal Medicine
  • Drug Resistance, Microbial
  • Child
  • Cells, Cultured
  • Adult